Yüklüyor......

Treatment of homozygous sickle cell disease with pentoxifylline.

This case report describes the sustained symptomatic and hematologic improvement in a 21-year-old woman with homozygous sickle cell (ss) disease during treatment with pentoxifylline, 400 mg three times daily after meals. Pain crises decreased from six to zero per year, hemoglobin level rose from 8.4...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Sacerdote, A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Medical Association 1999
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2608440/
https://ncbi.nlm.nih.gov/pubmed/12656436
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!